Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Details on Person Atomistic insights into the lung cancer-associated L755P mutation in HER2 resistance to lapatinib: a molecular dynamics study

Class:Id	LiteratureReference:9646493
_displayName	Atomistic insights into the lung cancer-associated L755P mutation in HER2 resistance to lapatinib: a molecular dynamics study
_timestamp	2019-05-24 18:42:55
author	[Person:9646495] Yang, Bei [Person:9646497] Zhang, Haiping [Person:8874146] Wang, Hao
created	[InstanceEdit:9646498] Orlic-Milacic, Marija, 2019-05-24
journal	J Mol Model
pages	24
pubMedIdentifier	25620423
title	Atomistic insights into the lung cancer-associated L755P mutation in HER2 resistance to lapatinib: a molecular dynamics study
volume	21
year	2015
(literatureReference)	[Pathway:9665251] Resistance of ERBB2 KD mutants to lapatinib [Homo sapiens] [FailedReaction:9665284] Resistant ERBB2 KD mutants do not bind lapatinib [Homo sapiens] [EntityWithAccessionedSequence:9646494] ERBB2 L755P [plasma membrane] [Homo sapiens] [EntityWithAccessionedSequence:9647196] p-6Y-ERBB2 L755P [plasma membrane] [Homo sapiens] [EntityWithAccessionedSequence:9654268] p-Y-ERBB2 L755P [plasma membrane] [Homo sapiens]
[Change default viewing format]

No pathways have been reviewed or authored by Atomistic insights into the lung cancer-associated L755P mutation in HER2 resistance to lapatinib: a molecular dynamics study (9646493)